Mark A Meltz insider trades

Open-market stock purchases and sales by Mark A Meltz, General Counsel at Lyell Immunopharma, Inc, from SEC Form 4 filings since Mar 28, 2019.

Recent trades

DateStockTradeValue
Feb 10, 2026LYEL Lyell Immunopharma, IncBought (not open market)—

Companies traded

  • LYEL Lyell Immunopharma, Inc: other filings, last Feb 10, 2026
  • KNTE Kinnate Biopharma Inc: other filings, last Apr 3, 2024
  • BOLD Audentes Therapeutics, Inc: other filings, last Jan 15, 2020

Get free alerts when Mark A Meltz files a new trade →